Considering the high prevalence and the lack of targeted pharmacological management of
acute kidney injury (AKI), the search for new therapeutic approaches for it is in urgent …

Aim The meta‐analysis of recent small animal experiments of mesenchymal stem/stromal
cells (MSC) therapy for impaired kidney could provide significant clues to design large …

Introduction Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

Chronic kidney disease (CKD) is a major health care problem, affecting more than 35% of
the elderly population worldwide. New interventions to slow or prevent disease progression …

This study aimed to evaluate the effect of mesenchymal stem cells (MSCs)–derived
exosomes in retina regeneration of experimentally induced diabetes mellitus (DM) in a …

MSCs show promise in protecting against IRI-induced damage. They appear to help
recovery mainly by affecting the levels of inflammation and apoptosis during the organ repair …

Ischemia-reperfusion and immunosuppressive therapy are a major cause of progressive
renal failure after kidney transplantation. Recent studies have shown that administration of …

Within the last years, the use of stem cells (embryonic, induced pluripotent stem cells, or
hematopoietic stem cells), Progenitor cells (eg, endothelial progenitor cells), and most …

Induced pluripotent stem (iPS) cells have potential for multilineage differentiation and
provide a resource for stem cell-based treatment. However, the therapeutic effect of iPS cells …

Mesenchymal stem cells are currently considered as a promising tool for therapeutic
application in acute kidney injury (AKI) management. AKI is characterized by acute tubular …